Back to search

Liver X receptor-α mediates cholesterol efflux in glomerular mesangial cells

Data up to Jan 2025

Published2004
Citations56
References44

Total Citations Per Year

Abstract

References (44)

Role of LXRs in control of lipogenesis

2000 • 1,623 citations

Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα

1998 • 1,408 citations

A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis

2001 • 1,287 citations

PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

2001 • 1,134 citations

LXR, a nuclear receptor that defines a distinct retinoid response pathway.

1995 • 1,089 citations

LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE

1982 • 1,021 citations

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

2002 • 913 citations

Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice

2000 • 846 citations

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

1998 • 667 citations

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

2001 • 643 citations

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats

1988 • 413 citations

Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice

2001 • 396 citations

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.

1996 • 378 citations

Cellular Lipid Metabolism and the Role of Lipids in Progressive Renal Disease

2004 • 269 citations

Putative Metabolic Effects of the Liver X Receptor (LXR)

2004 • 249 citations

Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans

1997 • 221 citations

Constitutive Activation of Peroxisome Proliferator-activated Receptor-γ Suppresses Pro-inflammatory Adhesion Molecules in Human Vascular Endothelial Cells

2002 • 211 citations

Peroxisome Proliferator-Activated Receptors, Coactivators, and Downstream Targets

2000 • 209 citations

Lipids and Progressive Glomerulosclerosis

1988 • 207 citations

Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Protects Against Nephropathy and Pancreatic Islet Abnormalities in Zucker Fatty Rats

1998 • 204 citations

Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

2001 • 190 citations

Early Mechanisms of Renal Injury in Hypercholesterolemic or Hypertriglyceridemic Rats

2000 • 189 citations

Accumulation of Foam Cells in Liver X Receptor-Deficient Mice

2002 • 185 citations

Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis.

1991 • 183 citations

Decoding Transcriptional Programs Regulated by PPARs and LXRs in the Macrophage

2003 • 152 citations

Peroxisome Proliferator-Activated Receptor γ: Implications for Cardiovascular Disease

2004 • 133 citations

PPAR Agonists Protect Mesangial Cells from Interleukin 1β-Induced Intracellular Lipid Accumulation by Activating the ABCA1 Cholesterol Efflux Pathway

2003 • 113 citations

Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation11See Editorial by van Zonneveld and Rabelink, p. 2037

2001 • 108 citations

The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility

2004 • 102 citations

LXRs: new therapeutic targets in atherosclerosis?

2003 • 101 citations

Cholesterol uptake in adrenal and gonadal tissues the SR BI and selective pathway connection

2003 • 99 citations

Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion

2000 • 98 citations

Peroxisome Proliferator-Activated Receptor γ Agonist Provides Superior Renal Protection versus Angiotensin-Converting Enzyme Inhibition in a Rat Model of Type 2 Diabetes with Obesity

2003 • 92 citations

LXRα functions as a cAMP-responsive transcriptional regulator of gene expression

2000 • 83 citations

Peroxisome proliferator-activated receptor-γ activity is associated with renal microvasculature

2001 • 75 citations

Nuclear hormone receptors and cholesterol trafficking: the orphans find a new home

2002 • 73 citations

Modulation of PPARγ activity with pharmaceutical agents: Treatment of insulin resistance and atherosclerosis

2003 • 63 citations

Native LDL Upregulation of ATP-Binding Cassette Transporter-1 in Human Vascular Endothelial Cells

2002 • 56 citations

Glomerular structures and lipids in progressive renal disease.

1989 • 49 citations

Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression

2003 • 49 citations

Inflammation modifies lipid-mediated renal injury

2002 • 41 citations

Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1

2003 • 38 citations

Relationship between Hyperlipidemia, Lipid Mediators, and Progressive Glomerulosclerosis in the Nephrotic Syndrome

1993 • 35 citations

Cloning and expression of the rabbit prostaglandin EP2 receptor.

2002 • 23 citations

Cited By (0)

Loading...